First Trust Amex Biotech Index Fund (FBT): Price and Financial Metrics ETF
GET POWR RATINGS... FREE!
FBT Stock Price Chart Interactive Chart >
FBT Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
Current price | $163.80 | 52-week high | $166.00 |
Prev. close | $165.37 | 52-week low | $121.68 |
Day low | $163.62 | Volume | 27,000 |
Day high | $166.00 | Avg. volume | 46,509 |
50-day MA | $157.36 | Dividend yield | 0.00001% |
200-day MA | $143.42 |
First Trust Amex Biotech Index Fund (FBT) ETF Bio
The investment objective of the First Trust Amex Biotech Index Fund ETF seeks to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.
FBT ETF Info
Issuer | First Trust Portfolios |
Expense Ratio | 0.55% |
Underlying Index | NYSE Arca Biotechnology Index |
Asset Class | Equity |
Sector | Health & Biotech ETFs |
Assets Under Management (AUM) | 1.58B |
Net Asset Value (NAV) | $165.07 |
Options? | Yes |
Total Holdings | 30 |
FBT Top Holdings
Symbol | Company | % of Total |
FGEN | FibroGen Inc. | 4% |
RARE | Ultragenyx Pharmaceutical Inc | 3.5% |
ILMN | ILLUMINA INC | 3.48% |
SGEN | Seattle Genetics Inc | 3.47% |
BMRN | Biomarin Pharmaceutical Inc | 3.46% |
AGIO | Agios Pharmaceuticals | 3.44% |
EXEL | EXELIXIS INC | 3.44% |
REGN | Regeneron Pharmaceuticals Inc | 3.44% |
IQV | IQVIA HOLDINGS | 3.43% |
ALKS | ALKERMES PLC | 3.4% |
FBT Price Returns
1-mo | 3.94% |
3-mo | 11.48% |
6-mo | 9.93% |
1-year | 9.98% |
3-year | 10.77% |
5-year | 22.86% |
YTD | 6.27% |
2022 | -4.83% |
2021 | -2.26% |
2020 | 12.96% |
2019 | 19.74% |
2018 | -0.30% |
FBT Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |